RESUMEN
BACKGROUND: Total coronary atherosclerotic plaque activity across the entire coronary arterial tree is associated with patient-level clinical outcomes. OBJECTIVES: We aimed to investigate whether vessel-level coronary atherosclerotic plaque activity is associated with vessel-level myocardial infarction. METHODS: In this secondary analysis of an international multicenter study of patients with recent myocardial infarction and multivessel coronary artery disease, we assessed vessel-level coronary atherosclerotic plaque activity using coronary 18F-sodium fluoride positron emission tomography to identify vessel-level myocardial infarction. RESULTS: Increased 18F-sodium fluoride uptake was found in 679 of 2,094 coronary arteries and 414 of 691 patients. Myocardial infarction occurred in 24 (4%) vessels with increased coronary atherosclerotic plaque activity and in 25 (2%) vessels without increased coronary atherosclerotic plaque activity (HR: 2.08; 95% CI: 1.16-3.72; P = 0.013). This association was not demonstrable in those treated with coronary revascularization (HR: 1.02; 95% CI: 0.47-2.25) but was notable in untreated vessels (HR: 3.86; 95% CI: 1.63-9.10; Pinteraction = 0.024). Increased coronary atherosclerotic plaque activity in multiple coronary arteries was associated with heightened patient-level risk of cardiac death or myocardial infarction (HR: 2.43; 95% CI: 1.37-4.30; P = 0.002) as well as first (HR: 2.19; 95% CI: 1.18-4.06; P = 0.013) and total (HR: 2.50; 95% CI: 1.42-4.39; P = 0.002) myocardial infarctions. CONCLUSIONS: In patients with recent myocardial infarction and multivessel coronary artery disease, coronary atherosclerotic plaque activity prognosticates individual coronary arteries and patients at risk for myocardial infarction.
Asunto(s)
Enfermedad de la Arteria Coronaria , Infarto del Miocardio , Placa Aterosclerótica , Humanos , Placa Aterosclerótica/diagnóstico por imagen , Placa Aterosclerótica/complicaciones , Infarto del Miocardio/epidemiología , Infarto del Miocardio/etiología , Masculino , Femenino , Persona de Mediana Edad , Enfermedad de la Arteria Coronaria/epidemiología , Enfermedad de la Arteria Coronaria/diagnóstico por imagen , Anciano , Tomografía de Emisión de Positrones , Vasos Coronarios/diagnóstico por imagen , Factores de RiesgoAsunto(s)
Amiloidosis , Cardiomiopatías , Paro Cardíaco , Insuficiencia Cardíaca , Mieloma Múltiple/complicaciones , Taquicardia Ventricular , Anciano , Amiloidosis/diagnóstico , Amiloidosis/etiología , Amiloidosis/fisiopatología , Amiloidosis/terapia , Cardiomiopatías/diagnóstico por imagen , Cardiomiopatías/etiología , Cardiomiopatías/fisiopatología , Cardiomiopatías/terapia , Ecocardiografía/métodos , Resultado Fatal , Femenino , Paro Cardíaco/diagnóstico , Paro Cardíaco/etiología , Paro Cardíaco/terapia , Insuficiencia Cardíaca/diagnóstico , Insuficiencia Cardíaca/etiología , Humanos , Imagen por Resonancia Cinemagnética/métodos , Marcapaso Artificial/efectos adversos , Intensificación de Imagen Radiográfica/métodos , Taquicardia Ventricular/diagnóstico , Taquicardia Ventricular/etiología , Taquicardia Ventricular/terapia , Tomografía Computarizada por Rayos X/métodosAsunto(s)
Foramen Oval Permeable/complicaciones , Intestinos/patología , Intestinos/trasplante , Isquemia/patología , Síndrome del Intestino Corto/complicaciones , Adulto , Estudios de Cohortes , Ecocardiografía , Femenino , Foramen Oval Permeable/terapia , Humanos , Masculino , Arteria Mesentérica Superior/cirugía , Persona de Mediana Edad , Perfusión , Cintigrafía , Síndrome del Intestino Corto/cirugía , Receptores de TrasplantesAsunto(s)
Aneurisma Infectado/diagnóstico por imagen , Endocarditis Bacteriana/complicaciones , Arteria Mesentérica Superior/diagnóstico por imagen , Tomografía de Emisión de Positrones , Radiofármacos , Tomografía Computarizada por Rayos X , Aneurisma Infectado/etiología , Endocarditis Bacteriana/diagnóstico por imagen , Fluorodesoxiglucosa F18 , Prótesis Valvulares Cardíacas/efectos adversos , Humanos , Masculino , Persona de Mediana Edad , Imagen Multimodal , Infecciones Relacionadas con Prótesis/complicaciones , Infecciones Relacionadas con Prótesis/diagnóstico por imagen , Staphylococcus epidermidis/patogenicidadAsunto(s)
Angina de Pecho/diagnóstico , Vasoespasmo Coronario/diagnóstico , Paro Cardíaco Extrahospitalario/etiología , Angina de Pecho/etiología , Síndromes Compartimentales/etiología , Vasoespasmo Coronario/complicaciones , Electrocardiografía , Femenino , Humanos , Persona de Mediana Edad , Taquicardia Sinusal/etiologíaRESUMEN
Introduction: The 2012 HRS/EHRA/ECAS guidelines encourage pre-procedural transesophageal echocardiography (TEE) prior to ablation for atrial fibrillation (AF), but acknowledge a lack of consensus in patients maintained on therapeutic warfarin before, during and after the procedure. This is partly because the incidence of left atrial appendage (LAA) thrombus is so low, that it is hard to draw clear conclusion regarding the characteristics of patients who develop thrombus. We hypothesize that the presence of low LAA emptying velocities, which predisposes to thrombus, and/or thrombus itself can be predicted in patients undergoing ablation, based upon clinical characteristics and transthoracic echocardiography (TTE). Methods: In this multicentre study, we undertook TTE and transesophageal echocardiograms (TEE) in 586 patients (age 59.9±0.4 years old, 64.5% male) undergoing catheter ablation for AF who were anticoagulated on warfarin (target international normalized ratio 2-3.5) for ≥3 consecutive weeks prior to procedure and maintained on warfarin for the procedure. Results: Low peak LAA emptying velocities (<40cm/s) were identified in 111 (24.7%) patients and LAA thrombus was identified in 3 patients (0.5%) despite having therapeutic INRs. The 3 patients with thrombus had LAA emptying velocities of 23, 29 and 31 cm/s. None of the remaining patients had a peri-procedural stroke. Patients with peak LAA emptying velocities <40cm/s or thrombus on TEE had significantly (p<0.05) higher CHA2DS2-VASc scores (1.7± 0.1 v's 1.4±0.1), and were more likely to have impaired LVSF (odds ratio [95% CI]: 2.66 [1.52-4.66]), a LA diameter >4.6cm on TTE (2.40 [2.13-5.41]), or persistent AF (2.60 [1.63-4.14]) compared to those with a higher LAA velocity without thrombus. Conclusion: In patients on uninterrupted warfarin therapy, a CHA2DS2-VASc score ≥1 or LA diameter >4.6cm on TTE identifies 91.5% of those at risk of developing thrombus with LAA emptying velocity of <40 cm/s and 100% of those with thrombus in our cohort.
RESUMEN
BACKGROUND: Testing of native myocardial function in patients with continuous-flow pumps is challenging as reduction/cessation of the pump could result in regurgitation, although the amount and significance of this regurgitation remains unknown. The aim of this study was to determine the optimal speed at which to assess the native left ventricular (LV) function and the physiologic response to speed reduction. METHODS: Fifteen male patients with a HeartMate II (HMII) device were studied prospectively on 46 occasions. Measurements were performed serially at three device speed settings: baseline speed; 6,000 rpm; and either 5,000 rpm (Group A) or 4,000 rpm (Group B). The device's forward and reverse velocity (Vmax(f), Vmax(r)), forward and reverse velocity time integral (VTI(f), VTI(r)) and blood volume (BV) were also measured using Doppler with LV echocardiographic parameters and peripheral hemodynamics. RESULTS: No adverse incidents were reported. Speed reduction to 6,000 rpm resulted in a significant decrease in Vmax(f), VTI(f) and BV. There was no significant difference in either forward or reverse flow with further speed reduction in either group. Speed reduction to <6,000 rpm did not have a significant effect on LV loading. CONCLUSIONS: Speed reduction in patients with the HMII device is safe. There was no difference between 6,000 rpm and lower speeds, suggesting that 6,000 rpm is sufficient to assess native myocardial function. The absence of significant retrograde filling suggests that LV loading is a physiologic response to speed reduction at 6,000 rpm.
Asunto(s)
Corazón Auxiliar , Corazón/fisiología , Flujo Sanguíneo Regional/fisiología , Adulto , Velocidad del Flujo Sanguíneo/fisiología , Ecocardiografía Doppler , Hemodinámica/fisiología , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Disfunción Ventricular Izquierda/fisiopatología , Disfunción Ventricular Izquierda/terapiaRESUMEN
BACKGROUND: Exercise electrocardiography (ETT) is frequently used in patients with suspected coronary artery disease (CAD). Single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) improves diagnostic stratification. There are no randomized trials comparing ETT and MPI. We hypothesized that first-line MPI would be effective and cost-saving versus ETT. METHODS AND RESULTS: We randomized 457 outpatients with stable chest pain and suspected CAD to either treadmill electrocardiography or MPI. The post-test likelihood incorporated the pretest likelihood and the test result, with clinically driven testing. The primary endpoint was cost to diagnosis based on institutional and National Institute for Clinical Excellence costs. MPI significantly reduced the intermediate post-test likelihood of CAD (30% for ETT vs 3% for MPI, P < .0001) and further investigations (71% for ETT vs 16% for MPI, P < .0001). Despite the reduction in downstream resource utilization after MPI, mean costs were not different between the 2 initial strategies: 490.44 pounds sterling (95% confidence interval, 453.80-527.08) for ETT versus 512.41 pounds sterling (95% confidence interval, 481.41-543.41) for MPI. MPI cost was no different from ETT cost in patients with an intermediate or high pretest likelihood (P = not significant). ETT was less expensive in low-risk patients. CONCLUSIONS: In this study there was no difference in cost to diagnosis between initial ETT and MPI. In low-likelihood patients ETT was less costly, whereas there was no cost difference in intermediate- or high-likelihood patients.
Asunto(s)
Dolor en el Pecho/diagnóstico , Dolor en el Pecho/economía , Enfermedad de la Arteria Coronaria/diagnóstico , Enfermedad de la Arteria Coronaria/economía , Electrocardiografía/economía , Prueba de Esfuerzo/economía , Costos de la Atención en Salud/estadística & datos numéricos , Tomografía Computarizada de Emisión de Fotón Único/economía , Anciano , Dolor en el Pecho/epidemiología , Dolor en el Pecho/etiología , Enfermedad de la Arteria Coronaria/epidemiología , Enfermedad de la Arteria Coronaria/etiología , Análisis Costo-Beneficio , Electrocardiografía/estadística & datos numéricos , Inglaterra/epidemiología , Prueba de Esfuerzo/estadística & datos numéricos , Femenino , Humanos , Masculino , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Tomografía Computarizada de Emisión de Fotón Único/estadística & datos numéricosRESUMEN
BACKGROUND: Technetium 99m N-ethoxy-N-ethyl dithiocarbamate (N-NOET) is a new radionuclide tracer for cardiac single photon emission computed tomography (SPECT) imaging. It combines the advantageous properties of a Tc-99m agent with the redistribution characteristics of thallium 201. We directly compared the two agents in patients with known or suspected coronary artery disease. METHODS AND RESULTS: Fifty patients underwent treadmill exercise Tc-99m N-NOET and Tl-201 SPECT studies. Images were acquired at stress, redistribution, and reinjection. Segmental analysis was carried out, and direct comparisons were made with corresponding segments. A stress score index was calculated and compared with the degree of lung uptake for each patient. From the 50 patients, 2657 of 2664 exercise, redistribution, and reinjection segments (99%) were interpreted. There was excellent agreement between the two modalities (weighted kappa = 0.83). Of the patients, 24 demonstrated reversible ischemia by Tl-201 SPECT reinjection imaging, of which Tc-99m N-NOET stress-redistribution imaging correctly identified 14 (58%); this improved significantly to 20 patients (83%) ( P = .03) when a reinjection protocol was used. A higher stress score index was seen in those patients with significant lung uptake (lung-heart ratio > or =0.6) after Tc-99m N-NOET stress imaging (1.6 vs 1.3, P = .03). CONCLUSION: SPECT imaging with Tc-99m N-NOET is comparable to Tl-201 for the diagnosis of coronary artery disease. Significant lung uptake with stress Tc-99m N-NOET may also indicate the severity of disease.